id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-313894-stgx36h5	Ürün, Yüksel	Survey of the Impact of COVID-19 on Oncologists’ Decision Making in Cancer	2020-08-05		.txt	text/plain	4279	270	47	PURPOSE: To understand readiness measures taken by oncologists to protect patients and health care workers from the novel coronavirus (COVID-19) and how their clinical decision making was influenced by the pandemic. In addition, the survey tool included questions regarding attitudes of medical oncologists around patient risk factors (age, performance status, comorbidities), administration of types of antineoplastic therapy (cytotoxic therapy, targeted therapy, immunotherapy), and use of therapy in differing settings (neoadjuvant, adjuvant v metastatic). Regarding perceptions about the safety of antineoplastic therapy, hormonal treatments and tyrosine kinase inhibitors (TKIs) were considered to be relatively safe, but cytotoxic chemotherapy and immune therapies CONTEXT Key Objective Does COVID-19 influence the decision-making process of oncologists? Likewise, neoadjuvant, adjuvant, and first-line metastatic disease was less affected, but most of the participants stated that they would be more reluctant to recommend second-or third-line therapies in the metastatic setting Relevance During the pandemic, the decision-making process of oncologists is significantly affected.	./cache/cord-313894-stgx36h5.txt	./txt/cord-313894-stgx36h5.txt